Category: GLOBE-NEWSWIRE

Posted on

EMGA secures US$ 15M financing for Banco Improsa in Costa Rica

LONDON, April 22, 2024 (GLOBE NEWSWIRE) — Emerging Markets Global Advisory LLP (EMGA), in partnership with Banco Improsa, announces that it has secured a US$15 million line of credit from The Japan International Cooperation Agency (JICA).

EMGA’s Head of Investment Banking and Managing Director of EMGA, Sajeev Chakkalakal, stated: “In spite of a challenging global macroeconomic environment, we are pleased to once again facilitate Banco Improsa’s continued vision to supporting SMEs in Costa Rica and complete this financing solution.”

Commenting on the transaction, Felix Alpizar Lobo, General Manager of Banco Improsa, said: “This financing reaffirms our commitment to strengthening the SME segment in Costa Rica. Banco Improsa is proud to share JICA’s objective of contributing to the economic and social growth of developing countries.”

EMGA’s Managing Director Jeremy Dobson added: “Banco Improsa’s strong management and healthy financial position were key factors in helping the EMGA Investment Banking team secure this funding, and this JICA facility will further strengthen Banco Improsa’s ability to grow its core SME lending book.”

JICA

The Japan International Cooperation Agency is a governmental agency that provides most of the Official Development Assistance for the Government of Japan. It is chartered with assisting the economic and social growth of developing countries, and the promotion international cooperation.

EMERGING MARKETS GLOBAL ADVISORY LLP (EMGA)

EMGA, with offices in London and New York, assists financial institutions and corporations seeking new debt or equity capital. EMGA’s multi-national team combine the decades of experience necessary to complete transactions on behalf of their clients within the world’s emerging markets and frontier economies, including Costa Rica which remains a key market. With a proven track record in capital formation and strategic advisory throughout diverse economic cycles, EMGA continues expanding its geographic reach and service offering, solidifying its place in the market as one of the industries pre-eminent emerging markets focused niche investment banks.

BANCO IMPROSA

It is a commercial bank with more than 37 years of experience, whose relational business model and focus on niche markets specializes in providing financing solutions and services to small and medium-sized enterprises (SMEs), among others. Banco Improsa was one of the first private banks in Costa Rica to offer non-financial services to its clients and has a long-standing history of providing advice and support to SMEs. Banco Improsa’s key success factor is its commitment to high standards of agile and flexible service, which, together with the offer of customized financial solutions, has enabled it to achieve a solid position in these segments.

Banco Improsa is a subsidiary of Grupo Financiero Improsa (GFI).

Contact details:
info@emergingmarketsglobaladvisory.com


GlobeNewswire Distribution ID 1000946184

Posted on

Concentrix + Webhelp Rebrands as Concentrix

Company’s rebranded identity solidifies its position as the global technology and services organization, powering the brands of the future

NEWARK, Calif., April 22, 2024 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader that has been operating under the trade name of Concentrix + Webhelp, today announced its transition to the Concentrix name and continued evolution of its brand.

Concentrix + Webhelp rebrand as Concentrix: Concentrix + Webhelp today announced its transition to the Concentrix name and continued evolution of its brand.

A Media Snippet accompanying this announcement is available by clicking on this link.

The Concentrix name is based on the concept of concentric circles, reflecting the company’s focus on keeping its people and clients always at the center, a concept that is still as relevant today as it was when the name was established. The newly designed visual identity represents the technology and transformative solutions that Concentrix delivers to power the brands of the future.

This rebrand reinforces the company’s continued commitment to bringing together a comprehensive and unmatched portfolio of capabilities. With an expanded breadth of generative AI solutions, digital capabilities, and high-value services, the company believes it has never been better positioned to deliver fully integrated, end-to-end solutions across the entire enterprise, at speed and scale.
“With this rebrand, we solidify our position as a leading technology and services company that is human-centered, tech-powered and intelligence-fueled,” said Chris Caldwell, President and CEO of Concentrix. “Whether it’s designing game-changing brand experiences, building and scaling secure AI technologies, or running digital operations, we bring together fully integrated solutions that solve our clients’ toughest business challenges.”

Today, Concentrix’ 2,000+ clients benefit from a robust, well-balanced footprint, backed by global consistency, local market expertise and a world-class portfolio of capabilities aligned to design, build, and run the cutting-edge solutions the company delivers.

To learn more about Concentrix, please visit concentrix.com.

About us: Experience the power of Concentrix
Concentrix Corporation (NASDAQ: CNXC) is a global technology and services leader that powers the world’s best brands, today and into the future. We’re human-centered, tech-powered, intelligence-fueled. Every day, we design, build, and run fully integrated, end-to-end solutions at speed and scale across the entire enterprise, helping over 2,000 clients solve their toughest business challenges. Whether it’s designing game-changing brand experiences, building and scaling secure AI technologies, or running digital operations that deliver global consistency with a local touch, we have it covered. At the heart of everything we do lies a commitment to transforming the way companies connect, interact, and grow. We’re here to redefine what success means, delivering outcomes unimagined across every major vertical in 70 + markets. Virtually everywhere. Visit concentrix.com to learn more.

Safe Harbor Statement
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, but are not limited to, statements regarding the company’s capabilities and positioning to deliver business outcomes and solve challenges for its clients, and statements that include words such as believe, expect, may, will, provide, could and should and other similar expressions. These forward-looking statements are inherently uncertain and involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, risks related to the company’s ability to successfully execute its strategy, competitive conditions in the company’s industry, and other factors contained in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2023 filed with the Securities and Exchange Commission and subsequent SEC filings. We do not undertake a duty to update forward-looking statements, which speak only as of the date on which they are made.

Copyright 2024 Concentrix Corporation
All rights reserved. Concentrix, Webhelp, Concentrix + Webhelp, the Concentrix and Webhelp logos, and all other Concentrix company, product and services names and slogans are trademarks or registered trademarks of Concentrix Corporation and its subsidiaries. Concentrix and the Concentrix logo Reg. U.S. Pat. & Tm. Off. and applicable non-U.S. jurisdictions. Other names and marks are the property of their respective owners.

Investor Contact:
Sara Buda
Investor Relations
Concentrix Corporation
investor.relations@concentrix.com

Media Contact:
Debbie Gonzalez
Marketing & Communications
Concentrix Corporation
media@concentrix.com

GlobeNewswire Distribution ID 9103218

Posted on

Revolutionary Scientists Honored for Advancements in Gene Therapy for Neuromuscular Diseases and RNA Discoveries: King Faisal Prize Laureates in Medicine, Professor Jerry Mendell, and in Science, Professor Howard Chang, Awarded

During its 46th session, King Faisal Prize Recognized Other Outstanding Figures in the Fields of Islamic Studies, and Service to Islam

Riyadh, Saudi Arabia, April 22, 2024 (GLOBE NEWSWIRE) — During the 46th session of King Faisal Prize on April 22, exceptional accomplishments in the fields of gene therapy for neuromuscular diseases and groundbreaking RNA discoveries were acknowledged. Professor Jerry Mendell was awarded the Medicine Prize for his groundbreaking contributions to the screening, early diagnosis, and treatment of neuromuscular disorders, notably spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). Professor Howard Chang received the Science Prize for unveiling the intrinsic role of long non-coding RNAs in gene regulation and function, a previously overlooked area of study.

Through innovative gene therapy approaches, Professor Mendell, the Director of Gene Therapy Center at Nationwide Children’s Hospital and Curran Peters Chair in Pediatric Research, has revolutionized treatment strategies, offering hope to countless patients worldwide.

Spinal muscular atrophy (SMA), once considered a leading genetic cause of infant mortality, has seen a paradigm shift in treatment due to Professor Mendell’s pioneering efforts. By utilizing gene therapy to deliver crucial genes to affected cells, he has significantly improved outcomes for patients, leading in 2019 to the first-ever FDA-approved gene therapy treatment for pediatric SMA patients (Zolgensma®).

In addition to his work in SMA, Professor Mendell’s research has extended to Duchenne muscular dystrophy and limb-girdle muscular dystrophy, showcasing the versatility and efficacy of gene therapy in addressing a spectrum of neuromuscular conditions. Genetic mutations in Duchenne muscular dystrophy (DMD) patients hinder the production of dystrophin, a crucial protein for muscle health. While initial symptoms primarily affect skeletal muscles, DMD progresses to impact cardiac and respiratory functions. Gene therapy offers a solution by addressing this genetic anomaly, allowing the body to produce dystrophin and halt muscle degeneration. In June 2023, the U.S. Food and Drug Administration approved the first treatment for pediatric DMD patients aged 4-5, utilizing a pioneering gene therapy co-developed by Professor Mendell and Professor Louise Rodino-Klapac, a former post-doctoral researcher in Mendell’s lab. This therapy involves a single injection, delivering a micro-dystrophin gene within an adeno-associated virus serotype (AAVrh74), facilitating the transfer of missing or corrected genes to cells.

He has played a significant role in clinical trials targeting different forms of Limb-Girdle Muscular Dystrophy (LGMD), characterized by muscle weakness affecting the shoulders, upper arms, hips, and upper legs. One study particularly concentrated on LGMD2B, demonstrating that a single injection of a gene therapy vector effectively restored damaged muscle fibers, mitigating degeneration, and improving muscle function.

Professor Mendell boasts a portfolio of more than 400 published papers, a testament to his prolific contributions to the field. In acknowledgment of his achievements, he was honored with election to the National Academy of Medicine in 2021. The American Society of Gene and Cell Therapy bestowed upon him the prestigious Translational Science Award named in his honor. Furthermore, in 2017, Science Magazine recognized his groundbreaking work in SMA Gene Therapy with the esteemed Breakthrough Achievement Award. His accolades also include numerous other awards and invitations to deliver honorary lectures at esteemed institutions.

In his acceptance speech during the ceremony, Professor Mendell said, “The principles of the award that reflect King Faisal’s intent to relieve human suffering are consistent with my own views and lifetime achievements. I have done everything I could do to improve the quality and prolong life for patients afflicted with neuromuscular diseases.”

On the frontier of molecular biology, Professor Howard Chang, a physician-scientist and Professor of Dermatology and Genetics, and Virginia and D.K. Ludwig Professor of Cancer Research at Stanford University, has been awarded King Faisal Prize for Science in Biology. Professor Chang’s elucidation of the role of long non-coding RNAs (lncRNAs) in gene regulation has revolutionized our understanding of cellular processes and disease mechanisms.

Through innovative genome-wide methodologies, Professor Chang has uncovered the intricate interplay between lncRNAs and gene expression, shedding light on fundamental biological processes underlying development, cancer, and aging. Despite not encoding proteins, lncRNAs are crucial for controlling the timing and amount of protein production, impacting the overall function and behavior of cells.

Within each human cell, a remarkable feat of organization unfolds: 2 meters of DNA are tightly packed into a nucleus merely 10 microns in size. This dense packaging renders most of the DNA inaccessible, except for the active DNA elements crucial to the cell’s functioning and reading. Identifying these accessible elements unveils invaluable insights into the cellular “software.” His groundbreaking techniques lie in mapping chromatin—the substance constituting chromosomes, comprised of DNA and associated proteins governing genome structure and gene expression. This has provided unprecedented insights into the regulatory mechanisms governing gene expression, paving the way for novel therapeutic interventions and precision medicine approaches. One technique is the Assay of Transposase Accessible Chromatin, employing the Tn5 transposase enzyme to efficiently copy and paste DNA. This revolutionary technique has yielded a million-fold enhancement in sensitivity and a hundred-fold improvement in mapping speed for regulatory DNA—the epigenome—in human cells.

As the founder of the RNA Medicine Program at Stanford University, Professor Chang continues to spearhead efforts to translate RNA science into tangible clinical applications, furthering the promise of RNA-based therapeutics in treating a wide range of diseases. Prof. Chang’s honors include the NAS Award for Molecular Biology, Outstanding Investigator Award of the National Cancer Institute, Paul Marks Prize for Cancer Research, Judson Daland Prize of the American Philosophical Society, and the Vilcek Prize for Creative Promise. His work was honored by the journal Cell as a Landmark paper over the last 40 years and by Science as “Insight of the decade”.

In his acceptance speech during the ceremony, Professor Chang said, “Our research asked a basic question: how do cells decide when and where to switch different genes on? How do these decisions get passed over time? Our studies led us to a new class of RNAs, called long noncoding RNAs, that help cells remember their cell fates. Our understanding of the gene switches led to an understanding of how inherited genetic differences cause disease, especially immune diseases. This understanding also helped to tackle mutations that arise in cancer.”

In addition to honoring advancements in medicine and science, King Faisal Prize also recognized exemplary contributions in Islamic Studies and Service to Islam.  Professor Wael Hallaq, among the top 500 scholars in Islamic Studies globally, was awarded the Islamic Studies prize for his groundbreaking contributions in guiding the development of Islamic legislation and challenging the narrative of closing of the gate of ijtihad – interpreting Islamic texts – gained prominence, reshaping accepted paradigms in the field.

The Japan Muslim Association and Mr. Mohammad El Sammak were honored for their exemplary leadership in serving Islam and humanity. The Japan Muslim Association is a pioneering Islamic organization for Japanese Muslims, renowned for its historic translation of the Holy Quran into Japanese, and its defense of Muslims’ affairs in Japan. And, Mr. Mohammad El Sammak, a pioneer in dialogue and bridge-building between different faiths, has made a lasting impact in interfaith dialogue over five decades. He was awarded for his effective contributions to conferences exploring Islam’s relationship with other beliefs and his leadership in institutions dedicated to tolerance and peace.

King Faisal Prize for Arabic Language & Literature for 2024 on the topic of “Non-Arab Institutions and their Endeavors to Promote Arabic” was withheld due to nominated works not elevating to the criteria of the prize.

Since 1979, King Faisal Prize in its 5 different categories has awarded 295 laureates who have made distinguished contributions to different sciences and causes. Each prize laureate is endowed with USD 200 thousand; a 24-carat gold medal weighing 200 grams, and a Certificate inscribed with the Laureate’s name and a summary of their work which qualified them for the prize.

Attachments

Maysa Shawwa
King Faisal Foundation
Maysa.Shawwa@kff.com

GlobeNewswire Distribution ID 9103755

Posted on

Giambattista Valli encanta Barcelona na Noite das Noivas

BARCELONA, Espanha, April 21, 2024 (GLOBE NEWSWIRE) — O desfile de moda mais exclusivo da Semana de Moda Nupcial de Barcelona encantou mais de 450 convidados na noite passada, que desfrutaram de um show único no edifício histórico da Llotja de Mar. A Maison Giambattista Valli comemorou com exclusividade a estreia de sua coleção nupcial na Noite das Noivas, a noite de gala do evento organizado pela Fira de Barcelona, com o apoio do Ministério de Negócios e Trabalho da Catalunha.

Em um desfile espetacular, as 30 criações de Giambattista Valli brilharam com sua luz própria. Foi o ponto culminante de silhuetas, representando uma exibição completa do conceito do Sr. Valli sobre vestidos de noiva contemporâneos, convidando o público a testemunhar de perto a manifestação de sua visão, traduzida em uma apresentação que incorpora a essência da individualidade, compartilhando um sonho, uma celebração e o amor.

O desfile de moda apresentou dez vestidos da terceira “Love Collection”, dez silhuetas icônicas da primeira e da segunda “Love Collections” e dez criações de alta costura, inspirando a grandiosidade e o savoir-faire dos Ateliês, distanciando-se dos rituais clássicos de casamento e concentrando-se no significado das emoções do “momento” e na alegria das cerimônias. Com a estética idílica e a excelência da Maison, os vestidos de Valli sobressaíram com um toque contemporâneo, seja pelas linhas limpas, pelos volumes inesquecíveis ou os detalhes inesperados, inspirados nas personalidades de um novo grupo imaginário: os amigos do Sr. Valli. Essa combinação de clássico e moderno atrai muitas noivas ao redor do mundo que buscam um vestido de noiva exclusivo, no puro estilo Valli e atrelado à sua própria história pessoal.

O conceituado estilista ficou encantado após o desfile e disse: “Escolhi Barcelona e a Semana de Moda Nupcial para a estreia da minha Love Collection 3 porque é um evento que atrai um público diversificado de entusiastas da moda, estilistas, compradores e mídia do mundo todo, além de me proporcionar o máximo de visibilidade internacional e oportunidades de sucesso”. E acrescentou: “Além disso, o clima romântico e cosmopolita de Barcelona combina perfeitamente com o tema de minha coleção, que celebra o amor e o romance“.

A Noite das Noivas de Barcelona contou com um público luxuoso e uma primeira fila que incluiu a modelo e ícone da moda internacional Olivia Palermo, a modelo e condessa Lara Cosima Henckel von Donnersmarck, o estilista e designer Pelayo Diaz, a atriz Hiba Abouk, a atriz e modelo Blanca Romero, o modelo Marco Llorente, a apresentadora de TV e atriz Marta Torné, entre outras personalidades.

Imagens disponíveis aqui.

Para atendimento à imprensa, entre em contato com:

Salvador Bilurbina
E-mail: sbilurbina@firabarcelona.com
Telefone: +34 628162674

GlobeNewswire Distribution ID 1000945947

Posted on

Giambattista Valli dazzles Barcelona during the Bridal Night

BARCELONA, Spain, April 19, 2024 (GLOBE NEWSWIRE) — The most exclusive fashion show of the Barcelona Bridal Fashion Week charmed over 450 guests last night who enjoyed a unique show in the historic building of the Llotja de Mar. The Maison Giambattista Valli exclusively celebrated the runway debut of its bridal collection during the Bridal Night, the gala evening of the event organized by Fira de Barcelona with the support of the Catalan Ministry of Business and Labor.

In an extraordinary show, Giambattista Valli’s 30 creations shone with their own light. It was a culmination of silhouettes, representing a comprehensive exhibition of Mr. Valli’s concept of contemporary bridal dressing, inviting his audience to witness the manifestation of his vision, translated into a presentation that embodies the essence of individuality, sharing a dream and a celebration and love.

The fashion show featured ten dresses from the third “Love Collection,” ten iconic silhouettes from the first and second “Love Collections” and ten Haute Couture creations, inspiring the magnificence and the savoir-faire of the Ateliers, stepping away from classic wedding rituals and focusing on the significance of the emotions of the “moment” and the joys of celebrations. Infused with the Maison’s idyllic aesthetic and excellence, Valli’s dresses stood out with a contemporary edge, whether through clean lines, unforgettable volumes or unexpected details inspired by the personalities of an imaginary new group – Mr. Valli’s friends. This blend of classic and modern appeals to many brides worldwide looking for a unique wedding gown, in pure Valli style and tied to their own personal storytelling.

The prestigious designer was delighted after the show and said that, “I chose Barcelona and Bridal Fashion Week for the debut of my Love Collection 3 because it is an event that attracts a diverse audience of fashion enthusiasts, designers, buyers and media from all over the world, and provides me with maximum global visibility and opportunities for success.” He added, “In addition, Barcelona’s romantic and cosmopolitan atmosphere matches perfectly with the theme of my collection, which celebrates love and romance.”

The Barcelona Bridal Night had a luxurious audience and front row, including it-girl, model and international fashion icon Olivia Palermo, model and countess Lara Cosima Henckel von Donnersmarck, stylist and designer Pelayo Diaz, actress Hiba Abouk, actress and model Blanca Romero, model Marco Llorente, and TV hostess and actress Marta Torné, among other personalities.

Images available here.

For media requests please contact:

Salvador Bilurbina
email: sbilurbina@firabarcelona.com
phone: +34628162674

GlobeNewswire Distribution ID 1000935713

Posted on

Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award

2024 Albert B. Sabin Gold Medal and 2024 Sabin Rising Star Award Presentations
Dr. Keith Klugman (left) and Dr. Shabir Madhi (right) were presented the 2024 Albert B. Sabin Gold Medal and Prof. Nicole Basta (center) received the 2024 Sabin Rising Star Award from the Sabin Vaccine Institute at the National Academy of Sciences in Washington, D.C.

WASHINGTON, April 19, 2024 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C.

Klugman and Madhi received the Sabin Gold Medal, one of the highest recognitions for vaccinologists globally, for their seminal combined contributions to the development of vaccines against pneumonia and diarrheal disease – major causes of death in children in low- and middle-income countries (LMICs). Klugman first met his then-graduate student Madhi at South Africa’s University of the Witwatersrand (also known as Wits University), where Klugman established, and Madhi expanded, a now globally renowned infectious diseases research institute. Apart from pneumonia, their work focused on maternal and children’s vaccines including influenza, respiratory syncytial virus (RSV), typhoid, and Group B streptococcus (GBS).

The evidence produced by these two awardees has and continues to inform the World Health Organization’s recommendations for vaccines. Klugman and Madhi’s research has helped pave the way for the introduction of lifesaving vaccines in public immunization programs – including the pneumococcal conjugate vaccine where their findings were pivotal in influencing vaccination policy in many LMICs.

“I am honored to award the Sabin Gold Medal to Dr. Klugman and Dr. Madhi for their extraordinary work on vaccines that have saved lives in communities most in need of these interventions,” says Amy Finan, Sabin’s chief executive officer. “Their pneumonia research has been particularly transformative in shaping our understanding of the disease and strengthening global health strategies to protect children from this vaccine-preventable disease.”

Fueled by an early interest in science as a child in South Africa — in part due to a physician father – Klugman holds both a medical as well as a science doctorate degree from Wits University and was the first student in the school’s history to obtain them simultaneously. He began his research career nearly five decades ago investigating the typhoid vaccine and has since distinguished himself as a formidable infectious diseases’ scientist. Klugman is widely known for his work on pneumonia, which still kills a child under five every 43 seconds, many in the world’s poorest countries. As the director of the pneumonia program at the Seattle-based Bill and Melinda Gates Foundation, Klugman orchestrates strategic initiatives aimed at reducing deaths from pneumonia, RSV, neonatal sepsis, and meningitis. He has authored hundreds of publications that have been cited over 50,000 times to date and has been elected to the National Academy of Medicine in the United States. Klugman is also a professor emeritus of global health at Atlanta’s Emory University.

His scientific achievements aside, Klugman has long championed the need for the world’s poorest children to have equitable access to vaccines. While in South Africa he joined in Wits University’s struggle to allow access to the institution for all students.

“It is absolutely wonderful to be receiving this award, especially together with Shabir,” he says. “When I look down the list of previous awardees, I recognize the great majority of them, and it is extraordinary to now be numbered among them.”

With a career spanning more than 25 years, Madhi, also from South Africa, is a trained pediatrician whose research continues to be instrumental in prioritizing the rollout of vital vaccines and guiding global public health policies. At Wits University, he led clinical trials focused on respiratory and meningeal pathogens, including vaccines targeted at pregnant women and their unborn babies. Madhi led the first study showing that a rotavirus vaccine could significantly prevent severe diarrhea during the first year of life in African infants. That research served as a key piece of evidence for the WHO’s recommendation of universal rotavirus vaccination. In addition, he also led the first two COVID-19 vaccine trials in Africa, and a number of COVID-19 epidemiology studies which led to the first evidence suggesting that infection-induced immunity and vaccinations played a role in reducing severity of disease.

Madhi heads South Africa’s widely respected South African Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (Wits VIDA) and is a professor of vaccinology at Wits. He too has co-authored hundreds of publications which have been cited over 59,000 times. Madhi is a recipient of numerous lifetime achievement awards in South Africa, as well being bestowed an Honorary Commander of the Order of the British Empire (CBE) from the British Government for his services to science and public health in a global pandemic.

“It is really humbling for me to be acknowledged for my contributions in the field of vaccinology along with those who have received the Gold Medal award,” says Madhi. “It makes me realize that the work my team and I have done is acknowledged by my peers as being of substance. Most significantly, we contributed to protecting lives in those settings where a majority of death and suffering occurs, and that is in LMICs.”

Sabin’s 2024 Rising Star Nicole Basta, an associate professor at Canada’s McGill University and Canada Research Chair in Infectious Disease Prevention, has led numerous studies to evaluate the impact of vaccines and vaccination programs for a number of globally challenging viral and bacterial diseases, including COVID-19, meningococcal disease, influenza, and HPV.

Inspired by her parents’ emphasis on the importance of education, Basta is a first-generation college graduate who earned an undergraduate degree at Princeton University and graduate degrees at the University of Cambridge and the University of Washington. She has distinguished herself as a prolific researcher with a focus on assessing the impact of vaccination programs and increasing vaccine awareness, acceptance, and uptake. She designed and led studies to evaluate the impact of the meningococcal A vaccine MenAfriVac in Mali and the meningococcal B vaccine Bexsero in the US, both of which contributed to better understanding about how to best implement vaccination programs. In 2020, she and a colleague developed an interactive online COVID-19 vaccine tracker, providing real-time updates to millions of users around the world on the pandemic vaccine development progress.

“Prof. Basta’s impactful and policy-shaping epidemiological research benefits from her ability to make it accessible and useful to the global health community. The COVID-19 vaccine tool is one such instance,” says Finan. “Those achievements alone would make her deserving of the Rising Star but there’s more: she also demonstrates a deep commitment to mentoring the next generation of public health researchers through her research group which is exactly the kind of emerging leader we need.”

Once an infectious diseases outbreak investigator with the Florida Department of Health, Basta has first-hand knowledge that scientific research needs to be understood and adopted beyond the confines of academia. She works with policy makers and public health agencies and organizations to translate research findings into actionable strategies for disease prevention and control.

“It’s truly an honor to receive the 2024 Rising Star Award from the Sabin Vaccine Institute, especially since I am deeply committed to ensuring that we have the evidence we need to demonstrate the importance of vaccination and increase access and uptake,” says Basta. “This recognition is also a testament to the outstanding collaborators and trainees I have had the privilege to work with and it motivates us to continue to make a difference in the years ahead.”

The Gold Medal is Sabin’s highest scientific honor. It has been given annually for more than three decades to a distinguished member of the global health community who has made exceptional contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. Barney Graham, Carol Baker, Bill Foege, Anne Gershon, Stanley Plotkin, and Kathrin Jansen.

Sabin’s Rising Star award was created in 2020 to encourage and recognize the next generation of vaccine and immunization leaders.

About the Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org and follow us on Twitter, @SabinVaccine.

Media Contact:
Monika Guttman
Senior Media Relations Specialist
Sabin Vaccine Institute
+1 (202) 662-1841
press@sabin.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/44d4ebd3-50bb-4e77-846d-0bad4accb05b

GlobeNewswire Distribution ID 9092558

Posted on

Révélation du thème de la 8e édition de la conférence Future Investment Initiative : « Horizons infinis : investir aujourd’hui pour façonner l’avenir »

fii8 concept theme

RIYAD, Arabie saoudite, 19 avr. 2024 (GLOBE NEWSWIRE) — Le Future Investment Initiative (FII) Institute se réjouit de dévoiler le thème de la 8e édition de sa conférence FII, prévue du 29 au 31 octobre 2024 au prestigieux Centre de conférences international du Roi Abdulaziz, dans la capitale saoudienne.

Organisée auteur du thème prometteur : « Horizons infinis : investir aujourd’hui pour façonner l’avenir », la FII 8e édition fera naître des débats sur la manière dont l’investissement peut servir d’incubateur vers un avenir prospère et durable, en repoussant les limites du possible pour le genre humain.

Rassemblant des leaders mondiaux, des entrepreneurs, des dirigeants politiques, des médias, mais aussi des décideurs dans les domaines de la finance, de l’IA, du développement durable, de l’énergie, de la géoéconomie, de l’industrie spatiale, et bien d’autres encore, la FII 8e édition promet d’être un creuset d’idées innovantes. En exploitant le thème des « Horizons infinis », la conférence 2024 entend inciter les participants à transcender les limites conventionnelles de la pensée et à explorer des opportunités d’investissement qui peuvent rapprocher les enjeux actuels des possibilités futures.

Richard Attias, PDG et membre du Conseil d’administration du FII Institute, a souligné l’importance de ce thème : « Horizons infinis est bien plus qu’un thème. C’est un vibrant appel à élargir notre vision collective et à embrasser les perspectives illimitées de l’avenir. Il représente notre engagement à susciter des débats menant vers un avenir où l’investissement ne connaît pas de limites et contribue à un meilleur avenir pour tous ».

Organisée par le Future Investment Initiative (FII) Institute, une organisation fondée par le PIF (Public Investment Fund), la conférence FII fera peau neuve à l’occasion de sa 8e édition, pour une semaine exclusivement réservée aux membres du FII Institute, aux délégués invités et aux partenaires stratégiques. Lors de la conférence, les discussions seront axées sur les données, afin de garantir que les idées sont fondées sur des faits et des stratégies exploitables.

Pour les demandes médias, veuillez contacter :

Téléphone : +966 53 978 2030

E-mail : Media@fii-institute.org

Le Future Investment Initiative (FII) Institute est une organisation à but non lucratif d’envergure mondiale dont la vocation est d’avoir un impact sur l’humanité. Par le biais de notre pôle d’investissement, nous encourageons l’innovation dans l’intelligence artificielle (ou IA) et la robotique, l’éducation, les soins de santé et le développement durable, afin de transformer les idées en solutions concrètes.

Une photo accompagnant cette annonce est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/fc52762c-6e57-4254-a6df-7f3b4af1c61b

GlobeNewswire Distribution ID 1000935626

Posted on

Apresentando o tema do 8º Fórum do Future Investment Initiative: “Horizontes Infinitos: Investindo Hoje, Moldando o Amanhã”

fii8 concept theme

RIYADH, Arábia Saudita, April 18, 2024 (GLOBE NEWSWIRE) — O Future Investment Initiative (FII) Institute tem o prazer de anunciar o tema para a próxima 8ª edição da conferência FII, marcada para 29 a 31 de outubro de 2024, no renomado Centro Internacional de Conferências Rei Abdulaziz (KAICC) em Riyadh, Arábia Saudita.

Com o instigante tema “Horizontes Infinitos: investindo hoje, moldando o amanhã”, a FII8 promoverá debates sobre como o investimento pode ser um catalisador para um futuro próspero e sustentável, ampliando os limites do que é possível para a humanidade.

A FII8 promete ser um caldeirão de ideias inovadoras, reunindo líderes globais, empreendedores, políticos, profissionais da mídia e tomadores de decisão em áreas como finanças, inteligência artificial, sustentabilidade, energia, geoeconomia, e até mesmo exploração espacial. Com o tema “Horizontes Infinitos”, a conferência deste ano desafiará os participantes a pensarem além dos limites convencionais e explorarem oportunidades de investimento que possam transcender os desafios atuais e abrir caminho para possibilidades futuras.

Richard Attias, CEO e membro do conselho do FII Institute, destacou a importância desse tema, afirmando que “Horizontes Infinitos não é apenas um lema; é um chamado claro para expandir nossa visão coletiva e abraçar as perspectivas ilimitadas do futuro. Isso representa nosso compromisso de promover conversas que levem a um futuro em que o investimento não tenha limites e contribua para um futuro melhor para todos.”

A FII8, organizada pelo FII Institute, estabelecida pelo PIF, trará um formato inovador como uma semana exclusiva para membros do FII Institute, delegados convidados e parceiros estratégicos. As discussões durante a conferência serão baseadas em dados, assegurando que as visões sejam fundamentadas em fatos e estratégias exequíveis.

Para comunicação social, entre em contato com:

Telefone: +966 53 978 2030

E-mail: Media@fii-institute.org

O Future Investment Initiative (FII) Institute é uma fundação global sem fins lucrativos dedicada a impactar a humanidade. Através do nosso braço de investimento, promovemos a inovação em Inteligência Artificial (IA) e Robótica, Educação, Saúde e Sustentabilidade, transformando ideias em soluções do mundo real.

Uma foto que acompanha este anúncio está disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/fc52762c-6e57-4254-a6df-7f3b4af1c61b

GlobeNewswire Distribution ID 1000935626

Posted on

Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals

BOSTON, April 18, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property (IP) management technology for corporations, law firms and governments, announces advancements in its Foreign Filing offering, enhancing the capabilities of its IP management platform, AQX®. Anaqua has shifted the paradigm of foreign filing for IP professionals from a burdensome set of manual administrative tasks to a strategic and automated differentiator, powering rapid decision-making for global IP protection.

In today’s competitive landscape, global IP practitioners understand the critical importance of protecting their innovation and inventions across borders. Anaqua’s advanced Foreign Filing within AQX offers a centralized ecosystem that addresses every aspect of the foreign filing lifecycle. On the AQX platform, customers can now utilize a decision workspace supported by competitive dashboards, foreign filing-specific reports, and online quoting to develop, execute, track, and manage their foreign filings. IP professionals can access a network of expert jurisdictional associates and translation providers to further improve the filing processes with transparent pricing and visibility into the process.

“Global businesses face increasing challenges in safeguarding their intellectual assets amidst rising innovation costs and intensifying competition,” said Bob Romeo, CEO of Anaqua. “At Anaqua, we have taken foreign filing far beyond any traditional provider. Our fully integrated solution drives clients’ efficiency and effectiveness, empowering IP professionals to navigate the complexities of global IP protection with confidence. Our clients are sharing our vision and our filing volume from the first quarter of 2024 has already surpassed our full-year filing volume for 2023.”

Through Anaqua’s enhanced Foreign Filing, IP professionals now have access to an end-to-end solution that not only streamlines the filing process, but also ensures transparency, cost-effectiveness, and peace of mind.

For more information about Anaqua’s Foreign Filing offering, please visit: anaqua.com/services/foreign-patent-filing/.

About Anaqua

Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX® and PATTSY WAVE®, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, Asia, and Australia. For additional information, please visit anaqua.com, or on Anaqua’s LinkedIn.

Company Contact:
Amanda Glagolev
Director, Communications
Anaqua
617-375-5808
aglagolev@anaqua.com

GlobeNewswire Distribution ID 9091488

Posted on

Anaqua transforme l’extension de brevets à l’international en avantage stratégique pour les professionnels de la PI

BOSTON, 18 avr. 2024 (GLOBE NEWSWIRE) — Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) pour les entreprises, les conseils et les administrations, annonce d’importantes améliorations dans son offre de services d’extension à l’international, renforçant ainsi les capacités de sa plateforme de gestion de la PI, AQX®. Anaqua a déjà considérablement fait évoluer le dépôt de brevet à l’étranger et libéré les professionnels de la PI de l’administration manuelle. Initialement qualifiée d’activité chronophage, l’extension à l’international constitue désormais un facteur de différenciation stratégique, mettant l’automatisation au service des décisions pour la protection de la PI.

Dans le contexte actuel hautement concurrentiel, les spécialistes de la PI mesurent l’importance capitale d’assurer la protection des innovations et des inventions à travers le monde. Intégré à AQX, le service d’extension internationale offre un écosystème centralisé qui couvre l’ensemble du cycle de vie d’un dépôt à l’étranger. Pour le développement, le suivi et la gestion de leur PI internationale, les clients disposent désormais d’un espace de décision sur la plateforme AQX avec des tableaux de bord performants, des rapports spécifiques et des devis en ligne. Les professionnels de la PI ont accès à un réseau d’experts juridiques et d’agences de traduction qui fluidifie les démarches de dépôt, tout en offrant plus de transparence tarifaire et de visibilité sur le processus.

« Aujourd’hui, face à une concurrence dynamique et des coûts d’innovation croissants, les entreprises internationales sont confrontées à des défis grandissants dans la protection de leurs actifs de PI », explique Bob Romeo, CEO d’Anaqua. « Chez Anaqua, nous avons repoussé les limites des dépôts à l’étranger, bien au-delà des fournisseurs de services traditionnels. Notre solution entièrement intégrée rend les professionnels de la PI plus efficaces en leur donnant les moyens de gérer en toute confiance la complexité de la protection intellectuelle à l’international. Nos clients adhèrent à cette vision et en récoltent les fruits : le nombre de dépôts au premier trimestre 2024 a déjà dépassé celui de toute l’année 2023. »

Avec l’amélioration des services d’extension internationale offerts par Anaqua, les professionnels de la PI disposent désormais d’une solution de bout en bout qui rationalise le processus de dépôt, mais leur apporte aussi transparence, rentabilité et tranquillité d’esprit.

Pour plus d’informations sur les services d’extension à l’international d’Anaqua, rendez-vous sur anaqua.com/fr/services/foreign-patent-filing/.

À propos d’Anaqua
Anaqua, Inc. est un fournisseur de premier plan de solutions et services technologiques intégrés de gestion de la propriété intellectuelle (PI). Ses logiciels, AQX® et PATTSY WAVE®, combinent les meilleurs outils pour définir une stratégie de propriété intellectuelle avisée. Ses technologies, qui reposent notamment sur des workflows et des capacités d’analyses avancés, offre un environnement de travail intelligent conçu pour une prendre de meilleures décisions et optimiser les opérations de PI. Aujourd’hui, près de la moitié des 100 premiers déposants de brevets américains et des marques mondiales, ainsi qu’un nombre croissant de cabinets de conseils en propriété intellectuelle dans le monde utilisent les solutions Anaqua. Plus d’un million de décideurs, avocats, juristes, gestionnaires et innovateurs utilisent la plateforme pour leurs besoins de gestion de la PI. Le siège de la société est situé à Boston, avec des bureaux aux États-Unis, en Europe, en Asie et en Australie. Pour de plus amples informations, veuillez consulter le site anaqua.com, ou la page entreprise d’Anaqua sur LinkedIn.

Contact presse :
Amanda Glagolev
Directrice de la communication
Anaqua
+1-617-375-5808
aglagolev@anaqua.com

GlobeNewswire Distribution ID 9091488

Posted on

EBC Financial Group Faz Parceria com a Unidos para Combater a Malária, Uma Campanha da Fundação das Nações Unidas, para Proteger Crianças Vulneráveis e Suas Famílias da Malária

EBC Financial Group Amplifica os Esforços de Erradicação da Malária, Apoiando Intervenções Críticas de Saúde e Empoderamento da Comunidade

Em frente ao Capitólio
EBC com delegados da Cúpula de Liderança da Campanha Unidos para Combater a Malária 2024 no Capitólio

EBC com delegados da Cúpula de Liderança da Campanha Unidos para Combater a Malária 2024 no Capitólio

WASHINGTON, April 17, 2024 (GLOBE NEWSWIRE) — O EBC Financial Group (EBC) anunciou hoje uma nova parceria com a Unidos para Combater a Malária (Beat Malaria), uma campanha da Fundação das Nações Unidas (UN Foundation), destinada a proteger os mais vulneráveis da malária – uma doença transmitida por mosquitos que mata mais de 600.000 pessoas todos os anos.

Esta parceria fornece apoio à campanha Unidos para Combater a Malária, que trabalha para melhorar o acesso à prevenção da malária e aos serviços essenciais de saúde em apoio ao objetivo da Fundação das Nações Unidas de alcançar um mundo mais saudável e equitativo. A Fundação das Nações Unidas reúne ideias, pessoas e recursos para impulsionar o progresso global e enfrentar os maiores desafios da humanidade. As iniciativas da Fundação das Nações Unidas protegeram coletivamente dezenas de milhões de crianças de doenças, formaram parcerias para fornecer ajuda e esperança aos refugiados e mobilizaram as comunidades para tomar medidas para a realização dos Objetivos de Desenvolvimento Sustentável.

A EBC tem a honra de se associar à campanha Unidos para Combater a Malária, unindo forças para eliminar de forma impactante com a malária. Essa parceria reflete a dedicação da EBC para com a responsabilidade social corporativa e ao apoio a crianças carentes. A EBC reconhece o profundo impacto da malária na saúde e no bem-estar das regiões atingidas pela pobreza e as repercussões econômicas subsequentes, particularmente no agravamento da disparidade entre regiões desenvolvidas e carentes. A malária afeta desproporcionalmente as crianças pequenas: mais de 75% de todas as mortes por malária são de crianças menores de 5 anos. Uma criança morre quase a cada minuto desta doença evitável e tratável.

“O convite para participar da Cúpula de Liderança da Unidos para Combater a Malária de 2024 e testemunhar a defesa em ação, além de ser um tremendo privilégio foi também uma experiência esclarecedora para mim”, disse David Barrett, CEO do EBC Financial Group (UK) Ltd, a entidade britânica da EBC. “Observar em primeira mão o impacto que o Grupo EBC pode ter ao envolver-se ativamente com organizações como a Unidos para Combater a Malária ressalta o nosso compromisso de fazer a diferença nas comunidades que servimos.”

Insights Colaborativos da Cúpula de Liderança da Campanha Unidos para Combater a Malária 2024
TBDra. Sara Hendrix, professora da University of Alabama e defensora do combate à malária, juntamente com o CEO David Barrett do EBC Financial Group (UK) Ltd.

Dra. Sara Hendrix, professora da University of Alabama e defensora do combate à malária, juntamente com o CEO David Barrett do EBC Financial Group (UK) Ltd.

“A nossa parceria com o Grupo EBC baseia-se num compromisso partilhado de proteger as crianças e famílias mais vulneráveis do mundo desta doença mortal, mas evitável”, disse Margaret McDonnell, Diretora Executiva da Beat Malaria. “O apoio da EBC permitirá que nossa campanha alcance comunidades em risco e forneça intervenções que salvam vidas em países endêmicos da malária, a fim de salvar e melhorar vidas.”

Hoje, a malária é uma doença da pobreza e da desigualdade na saúde. Ela é transmitida através das picadas dos mosquitos Anopheles, que carregam a doença potencialmente fatal causada pelo parasita sanguíneo Plasmodium. As ferramentas para prevenir, diagnosticar e tratar a malária são altamente econômicas, mas milhões de pessoas em todo o mundo não têm acesso a essas intervenções que salvam vidas. Metade da população mundial continua em risco de contrair malária, com mais de 240 milhões de casos por ano. A malária é mais prevalente na África, com 94% de todos os casos de todo o mundo, e afeta desproporcionalmente crianças pequenas, mulheres grávidas, populações deslocadas e comunidades remotas com acesso limitado aos cuidados de saúde.

O mundo já fez um progresso extraordinário contra esta doença antiga, reduzindo a taxa de mortalidade da malária em aproximadamente metade. Com financiamento, parceria e vontade política contínuos, podemos ser a geração que acabará com a malária para sempre.

Além do apoio financeiro, a EBC também procura educar seus funcionários sobre a malária e incentivá-los a se envolverem. No mês passado, Samuel Hertz, Diretor de Operações da APAC do EBC Financial Group, juntamente com David Barrett, juntaram-se a mais de 100 defensores, especialistas e líderes da malária na Cúpula de Liderança anual da Unidos para Combater a Malária em Washington DC. O evento de 3 dias foi uma plataforma para aprender, fazer networking e defender a liderança global, enfatizando a ação coletiva necessária para enfrentar esse desafio crítico de saúde pública. Além disso, os funcionários da EBC participarão do próximo Movimento Contra a Malária 5K (25 de abril a 5 de maio), uma corrida remota de 5K realizada em todo o mundo para arrecadar fundos e conscientizar sobre a malária.

Corrida de 5k Movimento Contra a Malária 2024
Entre 25 de abril e 5 de maio de 2024, junte-se aos apoiadores de todo o mundo no Movimento Contra a Malária, um evento virtual para aumentar a conscientização e os fundos para apoiar ferramentas e programas de tratamento da malária que salvam vidas.

Entre 25 de abril e 5 de maio de 2024, junte-se aos apoiadores de todo o mundo no Movimento Contra a Malária, um evento virtual para aumentar a conscientização e os fundos para apoiar ferramentas e programas de tratamento da malária que salvam vidas.

Samuel Hertz afirmou: “Nós, como empresa, estamos empenhados em ajudar as crianças de todo o mundo, reconhecendo a malária como uma das ameaças mais significativas às suas vidas. Na cúpula, obtivemos informações sobre o progresso alcançado na erradicação da malária a nível mundial. No entanto, este esforço requer um amplo apoio de diversos parceiros, e é por isso que estamos muito satisfeitos por nos juntarmos a esta coligação. Embora a jornada à frente possa ser desafiadora e prolongada, entendemos que mudanças significativas levam tempo e esforço. Como uma empresa global, a EBC reconhece sua responsabilidade de contribuir para um mundo melhor.”

Os defensores do EBC Financial Group estão unidos com os campeões globais na Cúpula de Liderança da Campanha Unidos para Combater a Malária, demostrando um compromisso coletivo para erradicar a malária e promover a equidade na saúde global.

Olhando para o futuro, a EBC pretende forjar colaborações mais profundas com organizações de caridade relacionadas à ONU e parceiros globais para reforçar os sistemas de saúde em todo o mundo. Por meio desses esforços e de seu compromisso com a responsabilidade social corporativa, a EBC visa aumentar a conscientização sobre as disparidades em saúde e promover a inclusão em escala global.

Para mais informação, visite ebc.com e beatmalaria.org.

Sobre o EBC Financial Group
Fundado no conceituado distrito financeiro de Londres, o EBC Financial Group (EBC) é conhecido pelo seu conjunto abrangente de serviços que incluem corretagem financeira, gestão de ativos e soluções de investimento abrangentes. Com escritórios estrategicamente localizados em centros financeiros proeminentes, como Londres, Sydney, Hong Kong, Tóquio, Singapura, Ilhas Cayman, Bangkok, Limassol e muitos outros, o EBC atende a uma clientela diversificada de investidores de varejo, profissionais e institucionais em todo o mundo.

Unidos por uma Causa: EBC Financial Group na Cúpula de Liderança da Campanha Unidos para Combater a Malária 2024

Os defensores do EBC Financial Group estão unidos com os campeões globais na Cúpula de Liderança da Campanha Unidos para Combater a Malária, demostrando um compromisso coletivo para erradicar a malária e promover a equidade na saúde global.

Reconhecido com várias premiações, o EBC se orgulha de aderir aos mais altos níveis de padrões éticos e regulamentações internacionais. O EBC Financial Group (UK) Limited é regulado pela Financial Conduct Authority (FCA) do Reino Unido, o EBC Financial Group (Australia) Pty Ltd é regulada pela Securities and Investments Commission (ASIC) da Austrália, e o EBC Financial Group (Cayman) Limited é regulado pela Cayman Islands Monetary Authority (CIMA).

No centro do Grupo EBC estão profissionais experientes com mais de 30 anos de profunda experiência em grandes instituições financeiras, tendo navegado habilmente por ciclos econômicos significativos, desde o Plaza Accord até a crise do franco suíço em 2015. O EBC defende uma cultura na qual a integridade, o respeito e a segurança dos ativos dos clientes são fundamentais, garantindo que todo o envolvimento dos investidores seja tratado com a máxima seriedade que merece.

https://www.ebc.com/

Sobre a Campanha Unidos para Combater a Malária da Fundação das Nações Unidas
A Fundação das Nações Unidas é uma organização de caridade independente criada para trabalhar em estreita colaboração com as Nações Unidas para enfrentar os maiores desafios da humanidade, criar iniciativas em todos os setores para resolver problemas em escala e impulsionar o progresso global. Saiba mais em www.unfoundation.org.

A campanha Unidos para Combater a Malária da Fundação das Nações Unidas reúne parceiros e apoiadores importantes e diversos para tomar medidas urgentes para acabar com a malária e criar um mundo mais saudável e equitativo. Desde 2006, a Unidos para Combater a Malária trabalha para equipar e mobilizar cidadãos dos EUA e de todo o mundo para aumentar a conscientização, os fundos e as vozes. A campanha trabalha com parceiros em países endêmicos para canalizar recursos que salvam vidas, para proteger as populações mais marginalizadas e vulneráveis. Ao defender uma maior liderança, vontade política e recursos dos EUA e de outros países, bem como ferramentas e estratégias mais holísticas e inovadoras, podemos ser a geração que acabará com a malária de uma vez por todas. Saiba mais em www.beatmalaria.org.

Contato com a Mídia:
Douglas Chew
douglas.chew@ebc.com

Fotos deste comunicado podem ser encontradas em:

https://www.globenewswire.com/NewsRoom/AttachmentNg/1c08cdbd-b10d-44ef-aaf6-f0485748b100/pt

https://www.globenewswire.com/NewsRoom/AttachmentNg/96d5b585-35c9-4d74-b552-11f682d457b9/pt

https://www.globenewswire.com/NewsRoom/AttachmentNg/714f58ca-2cdc-4c4c-ab91-0f2dbfad927e/pt

https://www.globenewswire.com/NewsRoom/AttachmentNg/9f2d5649-93d0-4619-bb12-0b4f422bcdd0/pt

GlobeNewswire Distribution ID 9091770

Posted on

EBC Financial Group s’associe à « Unis pour vaincre le paludisme », une campagne de la Fondation des Nations unies, pour protéger les enfants vulnérables et leurs familles contre le paludisme

EBC Financial Group intensifie les efforts d’éradication du paludisme en soutenant des interventions sanitaires essentielles et l’autonomisation des communautés

WASHINGTON, 18 avr. 2024 (GLOBE NEWSWIRE) — Aujourd’hui, EBC Financial Group (« EBC ») a annoncé un nouveau partenariat avec « Unis pour vaincre le paludisme » (United to Beat Malaria en anglais), une campagne de la Fondation des Nations unies, visant à protéger les personnes les plus vulnérables contre le paludisme – une maladie transmise par les moustiques qui coûte chaque année la vie à plus de 600 000 personnes.

Ce partenariat soutient la campagne « Unis pour vaincre le paludisme », qui vise à améliorer l’accès à la prévention du paludisme et aux services de santé essentiels, conformément à l’objectif de la Fondation des Nations unies, à savoir parvenir à un monde en meilleure santé et plus équitable. La Fondation des Nations unies rassemble des idées, des personnes et des ressources pour favoriser le progrès mondial et relever les plus grands défis de l’humanité. Les initiatives de la Fondation des Nations unies ont collectivement protégé des dizaines de millions d’enfants contre la maladie, formé des partenariats pour apporter aide et espoir aux réfugiés et mobilisé les communautés pour qu’elles agissent en vue de la réalisation des Objectifs de développement durable.

Devant le Capitole
EBC avec des délégués du sommet des dirigeants 2024 « Unis contre le paludisme » devant la Colline du Capitole

EBC avec des délégués du sommet des dirigeants 2024 « Unis contre le paludisme » devant la Colline du Capitole

EBC est honoré de s’associer à la campagne « Unis pour vaincre le paludisme » et d’unir ses forces pour éradiquer de manière efficace la maladie. Ce partenariat reflète l’engagement d’EBC en matière de responsabilité sociale des entreprises et de soutien aux enfants défavorisés. EBC reconnaît l’impact profond du paludisme sur la santé et le bien-être des régions touchées par la pauvreté, ainsi que les répercussions économiques qui en découlent, notamment en exacerbant la disparité entre les régions développées et les régions défavorisées. Le paludisme a un impact disproportionné sur les jeunes enfants : plus de 75 % des décès dus au paludisme concernent des enfants de moins de 5 ans. Un enfant meurt presque chaque minutes de cette maladie que l’on peut prévenir et traiter.

« Être invité au sommet des dirigeants de ‘Unis pour vaincre le paludisme’ en 2024 et assister à la mise en œuvre du plaidoyer a été pour moi non seulement un immense privilège, mais aussi une expérience enrichissante », a déclaré David Barrett, PDG d’EBC Financial Group (UK) Ltd, l’entité britannique d’EBC. « Observer depuis les premières loges l’impact que le groupe EBC peut avoir en s’engageant activement avec des organisations telles que ‘Unis pour vaincre le paludisme’ réaffirme notre engagement à faire évoluer la situation dans les communautés au service desquelles nous œuvrons ».

Perspectives de collaboration au sommet des dirigeants 2024 « Unis pour vaincre le paludisme »
Sara Hendrix, professeur à l’université d’Alabama et militante de l’initiative « Unis pour vaincre le paludisme », aux côtés de David Barrett, PDG d’EBC Financial Group (UK) Ltd.

Sara Hendrix, professeur à l’université d’Alabama et militante de l’initiative « Unis pour vaincre le paludisme », aux côtés de David Barrett, PDG d’EBC Financial Group (UK) Ltd.

« Notre partenariat avec le Groupe EBC repose sur un engagement commun à protéger les enfants et les familles les plus vulnérables du monde contre cette maladie mortelle, mais évitable », a confié Margaret McDonnell, directrice exécutive de la campagne « Unis pour vaincre le paludisme ». « Le soutien d’EBC permettra à notre campagne d’atteindre les communautés à risque et de déployer des interventions vitales dans les pays où le paludisme est endémique, afin de sauver des vies et d’améliorer le quotidien. »

Aujourd’hui, le paludisme est une maladie de la pauvreté et de l’inégalité en matière de santé. Elle est transmise à l’homme par les piqûres de moustiques anophèles, qui sont porteurs de la maladie mortelle causée par le parasite sanguin Plasmodium. Les outils de prévention, de diagnostic et de traitement du paludisme sont très bon marché, mais des millions de personnes dans le monde n’ont pas accès à ces dispositifs vitaux. La moitié de la population mondiale reste exposée au risque de paludisme, avec plus de 240 millions de cas recensés par an. C’est en Afrique que la prévalence du paludisme est la plus forte, avec 94 % de tous les cas recensés dans le monde. Il touche de manière disproportionnée les jeunes enfants, les femmes enceintes, les populations déplacées et les communautés isolées ayant un accès limité aux soins de santé.

Le monde a déjà accompli des progrès remarquables dans la lutte contre cette maladie ancienne, en réduisant de moitié environ le taux de mortalité dû au paludisme. Avec un financement continu, un partenariat et une volonté politique, nous pouvons être cette génération qui mettra fin au paludisme pour de bon.

Outre le soutien financier, EBC cherche également à sensibiliser ses employés au paludisme et à les encourager à s’impliquer. Le mois dernier, Samuel Hertz, directeur des opérations de la région APAC chez EBC Financial Group, et David Barrett ont rejoint plus de 100 défenseurs, experts et dirigeants de la lutte contre le paludisme lors du sommet annuel « Unis contre le paludisme » à Washington DC. Cet événement sur trois jours a été l’occasion d’apprentissage, de mise en réseau et de plaidoyer en faveur d’un leadership mondial, mettant l’accent sur l’action collective nécessaire pour relever ce défi crucial en matière de santé publique. Par ailleurs, les employés d’EBC participeront à la prochaine édition de Move Against Malaria 5K (du 25 avril au 5 mai), une course à pied de 5 km organisée partout dans le monde en vue de collecter des fonds et de sensibiliser le public au problème du paludisme.

Move Against Malaria 5k Run 2024
Du 25 avril au 5 mai 2024, rejoignez les supporters du monde entier pour Move Against Malaria, un événement virtuel visant à sensibiliser et à collecter des fonds pour soutenir les outils et les programmes de traitement du paludisme qui sauvent des vies.

Du 25 avril au 5 mai 2024, rejoignez les supporters du monde entier pour Move Against Malaria, un événement virtuel visant à sensibiliser et à collecter des fonds pour soutenir les outils et les programmes de traitement du paludisme qui sauvent des vies.

Samuel Hertz a déclaré : « EBC s’est engagée à aider les enfants du monde entier, en reconnaissant que le paludisme est l’une des menaces les plus graves pour leur vie. Lors du sommet, nous avons pu nous rendre compte des progrès accomplis dans l’éradication du paludisme à l’échelle mondiale. Toutefois, cette entreprise nécessite un soutien important de la part de divers partenaires, et c’est pourquoi nous sommes ravis de nous joindre à cette coalition. Bien que le voyage à venir puisse être difficile et de longue haleine, nous savons bien qu’un changement significatif nécessite du temps et des efforts. Entreprise mondiale, EBC reconnaît sa responsabilité de contribuer à un monde meilleur. »

Des partisans de l’initiative de chez EBC Financial Group se sont unis à des champions mondiaux lors du sommet des dirigeants « Unis pour vaincre le paludisme », témoignant d’un engagement collectif en faveur de l’éradication du paludisme et de la promotion de l’équité en matière de santé dans le monde.

À l’avenir, EBC prévoit d’approfondir sa collaboration avec des organisations caritatives rattachées aux Nations unies et des partenaires mondiaux afin de renforcer les systèmes de santé dans le monde entier. Grâce à ces efforts et à son engagement en matière de responsabilité sociale des entreprises, EBC vise à sensibiliser aux disparités en matière de santé et à promouvoir l’inclusion à l’échelle mondiale.

Pour plus d’informations, consultez les sites ebc.com et beatmalaria.org.

À propos d’EBC Financial Group
Fondé dans le prestigieux quartier financier de Londres, EBC Financial Group (« EBC ») est réputé pour sa gamme complète de services qui comprend le courtage financier, la gestion d’actifs et des solutions d’investissement globales. Avec des bureaux stratégiquement situés dans des centres financiers de premier plan, tels que Londres, Sydney, Hong Kong, Tokyo, Singapour, les îles Caïmans, Bangkok, Limassol, et bien d’autres villes encore, EBC s’adresse à une clientèle diversifiée d’investisseurs de détail, professionnels et institutionnels aux quatre coins du globe.

Unis pour une cause : EBC Financial Group au sommet des dirigeants 2024 « Unis pour vaincre le paludisme »

Des partisans de l’initiative de chez EBC Financial Group se sont unis à des champions mondiaux lors du sommet des dirigeants « Unis pour vaincre le paludisme », témoignant d’un engagement collectif en faveur de l’éradication du paludisme et de la promotion de l’équité en matière de santé dans le monde.

Reconnu par de multiples récompenses, EBC est fier d’adhérer aux niveaux les plus élevés de normes éthiques et de réglementation internationale. EBC Financial Group (UK) Limited est réglementé par la Financial Conduct Authority (« FCA ») du Royaume-Uni, EBC Financial Group (Australia) Pty Ltd est réglementé par la Securities and Investments Commission (« ASIC ») australienne, et EBC Financial Group (Cayman) Limited est réglementé par la Monetary Authority (« CIMA ») des îles Caïmans.

Au cœur d’EBC Group sont réunis des professionnels chevronnés qui témoignent de plus de 30 ans d’expérience approfondie dans des institutions financières majeures, ayant habilement navigué à travers des cycles économiques importants, des Accords du Plaza à la crise du franc suisse de 2015. EBC défend une culture où l’intégrité, le respect et la sécurité des actifs des clients sont primordiaux, en veillant à ce que chaque engagement d’investisseur soit traité avec le plus grand sérieux qu’il mérite.

https://www.ebc.com/

À propos du programme « Unis pour vaincre le paludisme » de la Fondation des Nations unies
La Fondation des Nations unies est une organisation caritative indépendante créée pour travailler en étroite collaboration avec les Nations unies afin de relever les plus grands défis de l’humanité, de mettre en place des initiatives intersectorielles pour résoudre les problèmes à grande échelle et de favoriser le progrès au niveau mondial. Pour en savoir plus, consultez le site www.unfoundation.org.

La campagne « Unis pour vaincre le paludisme » de la Fondation des Nations unies réunit des partenaires et des sympathisants importants et de tous horizons afin de prendre des mesures urgentes pour mettre fin au paludisme et créer un monde en meilleure santé et plus équitable. Depuis 2006, « Unis pour vaincre le paludisme » s’efforce d’éduquer et de mobiliser les citoyens aux États-Unis et de par le monde pour sensibiliser l’opinion publique, collecter des fonds et faire entendre leur voix. La campagne collabore avec des partenaires dans les pays endémiques afin d’acheminer des ressources vitales pour protéger les populations les plus marginalisées et les plus vulnérables. En nous faisant les chantres d’un leadership, d’une volonté politique et de ressources accrus de la part des États-Unis et d’ailleurs, ainsi que d’outils et de stratégies plus holistiques et novateurs, nous pouvons être la génération qui mettra fin au paludisme une fois pour toutes. Pour en savoir plus, consultez le site www.beatmalaria.org.

Contact auprès des médias :
Douglas Chew
douglas.chew@ebc.com

Les photos jointes au présent communiqué sont disponibles aux adresses suivantes :

https://www.globenewswire.com/NewsRoom/AttachmentNg/1c08cdbd-b10d-44ef-aaf6-f0485748b100/fr

https://www.globenewswire.com/NewsRoom/AttachmentNg/96d5b585-35c9-4d74-b552-11f682d457b9/fr

https://www.globenewswire.com/NewsRoom/AttachmentNg/714f58ca-2cdc-4c4c-ab91-0f2dbfad927e/fr

https://www.globenewswire.com/NewsRoom/AttachmentNg/9f2d5649-93d0-4619-bb12-0b4f422bcdd0/fr

GlobeNewswire Distribution ID 9091770